Product Information
AZITHROMYCIN 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2676 per EA under NDC 50111078751. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 14, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111078751
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065225FDA Approved
11/14/2005
TE Code
AB
On Market Since
1/6/2006
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 250 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 46.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2676 per EA |
|---|---|
| All-time high | $0.6928 (May 16, 2018) |
| All-time low | $0.2563 (Nov 20, 2024) |
| 52-week high | $0.3716 |
| 52-week low | $0.2676 |
| Median price | $0.4815 |
| Average price | $0.4708 |
| Largest weekly change | +39.5% (Nov 23, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2676 per EA (NDC 50111078751), effective Aug 19, 2026.
How has the price of AZITHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 250 MG TABLET has declined 46.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 250 MG TABLET?
Since Nov 28, 2013, the NADAC for AZITHROMYCIN 250 MG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.6928 (May 16, 2018), with a median of $0.4815 per EA.
Are there cheaper alternatives to AZITHROMYCIN 250 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AZITHROMYCIN 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AZITHROMYCIN 250 MG TABLET?
AZITHROMYCIN 250 MG TABLET (NDC 50111078751) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.